ClinicalTrials.gg
RecruitingNCT07732257Updated Jul 28, 2026

Wireless MicroPremVitals Button Sensor in the NICU

An interventional study of Wireless MicroPremVitals Button Sensor System in Premature Birth, Fragility and Apnea of Prematurity, sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre. Recruiting at 1 site in Canada. Per ClinicalTrials.gov, last updated 2026-07-28.

Sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre · Not applicable, Interventional, and Device feasibility

From the registry’s dates

  • Started Jun 2026; still recruiting 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Non-randomized
Sex
All
01

Study summary

A wireless and miniaturized vital sign (ECG, SpO2, Skin Temperature) sensor system, MicroPremVitals Button Sensors was developed by the Dr. John Rogers Laboratory (QSIB- Northwestern University, Chicago, USA) to facilitate vital sign monitoring in extremely preterm neonates.

Read the detailed description

Building on prior collaborative work between the Smart Hospital Project and the Dr. John Rogers Laboratory (QSIB- Northwestern University, Chicago, USA) in skin-integrated, soft, flexible electronics for premature infants, these button-sized sensors are designed to provide continuous ECG, oxygen saturation (SpO₂), and skin temperature monitoring without the bulky wires and large adhesives that impact the most fragile infants. By miniaturizing the hardware and tailoring form factor, weight, and interface materials for fragile neonatal skin, the system aims to extend wireless, clinical-grade monitoring down to the smallest, sickest babies.

In the NICU, the possible use of wireless sensors has received positive feedback from parents and HCPs. Overall, the perception is that eliminating the wires and cables will facilitate sensors application and monitoring, improve patient comfort, and skin-to-skin contact between infants and parents.

This proposal aims to:

  1. Investigate the feasibility, safety, and accuracy of the Wireless MicroPremVitals Button Sensors monitoring system specifically developed for use in extremely preterm neonates.
  2. Assess parents and HCPs perspectives on standard and wireless vital sign monitoring systems in extremely preterm infants.
02

Conditions studied

  • Premature Birth
  • Fragility
  • Apnea of Prematurity
  • Bradycardia Neonatal
  • Sepses, Neonatal

Keywords

  • ecg
  • vital sign
  • birth
  • neonate
  • resuscitation
  • prematurity
  • micropreterm
  • micropreemie
03

In context

Premature Birth

2,550 studies on the registry are indexed under Premature Birth; 500 are open to participants now.

This study's planned enrollment of 10 is below the median of 84 across 1,666 interventional studies indexed under Premature Birth.

Browse Premature Birth studies →

Lead sponsor

McGill University Health Centre/Research Institute of the McGill University Health Centre is the lead sponsor of 421 studies on the registry; 105 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Infants admitted to the NICU with a gestational age of ≥ 22+0 weeks and ≤ 29+6 weeks at birth,
  • AND >72h of age at time of study,
  • AND clinically stable,
  • AND with the Neonatal Nurse Practitioner (i.e., NNP) and Healthcare Team in agreement for the patient to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • Infants with a skin abnormality that would potentially increase the risk of injury,
  • patient too unstable or family experiencing too much stress as determined by an attending physician or bedside care team to not be approached for recruitment.
  • Infants admitted to the NICU with a gestational age of \< 22+0 weeks or > 29+6 weeks at birth,
  • and/or ≤ 72h of age at time of study,
  • and/or not meeting all requirements of clinical stability,
  • and/or with the Neonatal Nurse Practitioner (i.e., NNP)/Healthcare Team in disagreement for the patient to participate in the study.
05

Study design

Phase
Not applicable
Primary purpose
Device feasibility
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
10 participants (estimated)

Study arms

  • Experimental
    Extremely Preterm Infant

    The Wireless MicroPremVitals Button Sensor System consists of three (3) sensors: a chest unit, a forehead unit, and a limb unit. In this study, the MicroPremVitals Button forehead sensor will be mounted on the cerebral area of neonates at the level of the forehead. The chest unit will be mounted on the chest, between the nipples, or slightly below the nipple-line as placement allows. The limb unit will be mounted on the outer surface of the hand, wrist, or ankle of any limbs, as placement with standard wired equipment allows.

    Device: Wireless MicroPremVitals Button Sensor System

  • Experimental
    Micro Preterm Infant

    The Wireless MicroPremVitals Button Sensor System consists of three (3) sensors: a chest unit, a forehead unit, and a limb unit. In this study, the MicroPremVitals Button forehead sensor will be mounted on the cerebral area of neonates at the level of the forehead. The chest unit will be mounted on the chest, between the nipples, or slightly below the nipple-line as placement allows. The limb unit will be mounted on the outer surface of the hand, wrist, or ankle of any limbs, as placement with standard wired equipment allows.

    Device: Wireless MicroPremVitals Button Sensor System

Interventions

  • DeviceWireless MicroPremVitals Button Sensor System

    These button-sized sensors are designed to provide continuous ECG, oxygen saturation (SpO₂), and skin temperature monitoring without the bulky wires and large adhesives that impact the most fragile infants.

06

What researchers measure

Primary outcomes

  1. HR Accuracy

    Comparison of heart rate measured by the Wireless MicroPremVitals Button Sensor System and the Philips IntelliVue MX800.

    Time frame: 6 months

  2. Oxygen Saturation Accuracy

    Comparison of SpO₂ measured by the Wireless MicroPremVitals Button Sensor System and the Philips IntelliVue MX800.

    Time frame: 6 months

  3. Skin Temperature Accuracy

    Comparison of skin temperature measured by the Wireless MicroPremVitals Button Sensor System and the Philips IntelliVue MX800.

    Time frame: 6 months

Secondary outcomes

  1. Perspectives

    Clinician and parent/guardian perspectives on both the Wireless MicroPremVitals Button Sensor System and the wired vital sign monitoring system, will be assessed using a custom study questionnaire. The questionnaire includes Likert-scale items, multiple-choice questions, and open-ended responses evaluating usability, perceived safety, accuracy, comfort, and acceptability. Responses will be summarized descriptively by questionnaire item.

    Time frame: 6 months

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07732257
Collaborators
Northwestern Querrey Simpson Institute for Bioelectronics (QSIB)
Responsible party
Guilherme Sant'Anna, MD (Senior Clinician Scientist, Professor, McGill University Health Centre/Research Institute of the McGill University Health Centre) — Principal investigator
First posted
Jul 28, 2026
Start date
Jun 19, 2026
Primary completion
Jan 30, 2027 (estimated)
Completion
Mar 30, 2027 (estimated)
Last update
Jul 28, 2026

Study contacts

Alyssa Maximov
Contact
alyssa.maximov@muhc.mcgill.ca
5149341934 ext. 78229
Guilherme Sant'Anna, MD, PhD
principal investigator · The Research Institute of the McGill University Health Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion